Impact of Prestroke Selective Serotonin Reuptake Inhibitor Treatment on Stroke Severity and Mortality | Zendy

Janne Kaergaard Mortensen | Zendy; Heidi Larsson | Zendy; Søren Paaske Johnsen | Zendy; Grethe Andersen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Prestroke Selective Serotonin Reuptake Inhibitor Treatment on Stroke Severity and Mortality

Author(s) -

Janne Kaergaard Mortensen,

Heidi Larsson,

Søren Paaske Johnsen,

Grethe Andersen

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.114.005302

Subject(s) - medicine , stroke (engine) , odds ratio , confidence interval , propensity score matching , serotonin reuptake inhibitor , depression (economics) , logistic regression , physical therapy , anesthesia , antidepressant , mechanical engineering , macroeconomics , hippocampus , engineering , economics

Selective serotonin reuptake inhibitors (SSRIs) have been associated with an increased risk of bleeding but also a possible neuroprotective effect in stroke. We aimed to examine the implications of prestroke SSRI use in hemorrhagic and ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research